EAT

(redirected from MCL1)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms.

expected approach clearance (EAC)

An expression used in radio communications to indicate the time at which arriving aircraft should be cleared to begin the approach for a landing. Also known as EAT, or expected approach time.
References in periodicals archive ?
Seven genes (IL16, CCL1, EEF1G, CD84, MCL1, NFATC4 and IER-5) did not reveal any significant difference between Tharparkar and Vrindavani.
Until now, however, MCL1's role in heart muscle cells was unclear.
It is important to note that these results do not demonstrate that miR-125b directly decreases the expression of BAK1, CASP2, MAP2K7, and MCL1 upon exposure to formaldehyde, nor that miR-142-3p directly increases the expression of ITGB8.
The newly announced clinical milestone is related to the first treatment of the first patient in a trial sponsored by Servier, in which a selective Mcl1 inhibitor, which was identified through the collaboration, is being explored.
In vitro studies showed that siRNA knockdown of antiapoptotic molecules BCL2 and MCL1 leads to reduction of the proliferation of TET cell lines.
In addition, GSK-3[beta]-mediated phosphorylation of BCL2 family member MCL1 has been demonstrated to induce axonal autophagy and axonal degeneration [114].
DSW 1200 upregulated expression of Fas, Gadd45a, and Mcl1. DSW 1200 downregulated expression of Aifm1, Api5, Bag1, Cideb, Cycs, and Pycard.
indicated that metformin combined with aspirin synergistically inhibited tumor growth, migration, and colony formation in human pancreas cancer PANC-1 and BxPC-3 cells cultured in vitro and pancreas tumor xenografts in nude mice, by remarkably inhibiting the phosphorylation of STAT3 and mTOR, significantly downregulating the antiapoptotic proteins Bcl-2 and Mcl1 and significantly upregulating the proapoptotic proteins Puma and Bim [48].
Sheldrake et al., "The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl1 to override pro-inflammatory signalling and drive neutrophil apoptosis," European Journal of Immunology, vol.
In CLL, some other apoptosis related genes were identified to be targets of miR-15a and miR-16-1 cluster, such as MCL1, which could enhance cell survival by inhibiting apoptosis.
Furthermore, inhibition of GSK3 kinase resulted in significant downregulation of splicing factors (SRSF1, SRSF5, PTPB1, and hnRNP) in U87 cells with downregulation of antiapoptotic genes such as BCL2, BCL-xL, Survivin, MCL1, and BMI1.
The common leads used clinically for monitoring are Lead II and V1 (MCL1).